Detailed information for compound 226775

Basic information

Technical information
  • TDR Targets ID: 226775
  • Name: 2-[4-[2,2-bis(4-fluorophenyl)ethylamino]piper idin-1-yl]-N,9-bis(prop-2-enyl)purin-6-amine
  • MW: 529.627 | Formula: C30H33F2N7
  • H donors: 2 H acceptors: 3 LogP: 5.95 Rotable bonds: 11
    Rule of 5 violations (Lipinski): 2
  • SMILES: C=CCNc1nc(nc2c1ncn2CC=C)N1CCC(CC1)NCC(c1ccc(cc1)F)c1ccc(cc1)F
  • InChi: 1S/C30H33F2N7/c1-3-15-33-28-27-29(39(16-4-2)20-35-27)37-30(36-28)38-17-13-25(14-18-38)34-19-26(21-5-9-23(31)10-6-21)22-7-11-24(32)12-8-22/h3-12,20,25-26,34H,1-2,13-19H2,(H,33,36,37)
  • InChiKey: ATAAXLOHXYSKEX-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N,9-diallyl-2-[4-[2,2-bis(4-fluorophenyl)ethylamino]-1-piperidyl]purin-6-amine
  • N,9-diallyl-2-[4-[2,2-bis(4-fluorophenyl)ethylamino]-1-piperidinyl]-6-purinamine
  • allyl-[9-allyl-2-[4-[2,2-bis(4-fluorophenyl)ethylamino]piperidino]purin-6-yl]amine
  • 2-[4-[2,2-bis(4-fluorophenyl)ethylamino]piperidin-1-yl]-N,9-di(prop-2-enyl)purin-6-amine
  • [1-[9-allyl-6-(allylamino)purin-2-yl]-4-piperidyl]-[2,2-bis(4-fluorophenyl)ethyl]amine

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Voltage-gated L-type calcium channel alpha-1S subunit Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma mansoni high voltage-activated calcium channel Cav1 Get druggable targets OG5_126791 All targets in OG5_126791
Echinococcus granulosus voltage dependent calcium channel Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum Voltage-dependent P/Q-type calcium channel subunit alpha-1A, putative Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum ko:K04853 calcium channel, voltage-dependent, L type, alpha 1F subunit, putative Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum expressed protein Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum Voltage-dependent P/Q-type calcium channel subunit alpha-1A, putative Get druggable targets OG5_126791 All targets in OG5_126791
Echinococcus granulosus voltage dependent L type calcium channel subunit|voltage dependent calcium channel Get druggable targets OG5_126791 All targets in OG5_126791
Echinococcus multilocularis voltage dependent calcium channel Get druggable targets OG5_126791 All targets in OG5_126791
Echinococcus granulosus voltage dependent calcium channel type d subunit|voltage dependent calcium channel alpha 1 Get druggable targets OG5_126791 All targets in OG5_126791
Neospora caninum hypothetical protein Get druggable targets OG5_126791 All targets in OG5_126791
Echinococcus multilocularis voltage dependent L type calcium channel subunit Get druggable targets OG5_126791 All targets in OG5_126791
Trypanosoma congolense Voltage-dependent calcium channel subunit, putative Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum Muscle calcium channel subunit alpha-1, putative Get druggable targets OG5_126791 All targets in OG5_126791
Trypanosoma cruzi Voltage-dependent calcium channel subunit, putative Get druggable targets OG5_126791 All targets in OG5_126791
Loa Loa (eye worm) voltage-dependent calcium channel Get druggable targets OG5_126791 All targets in OG5_126791
Toxoplasma gondii transporter, cation channel family protein Get druggable targets OG5_126791 All targets in OG5_126791
Echinococcus multilocularis voltage dependent calcium channel Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum Probable voltage-dependent R-type calcium channel subunit alpha-1E, putative Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum Voltage-dependent P/Q-type calcium channel subunit alpha-1A, putative Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum expressed protein Get druggable targets OG5_126791 All targets in OG5_126791
Trypanosoma brucei gambiense calcium channel protein, putative Get druggable targets OG5_126791 All targets in OG5_126791
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum ko:K04344 calcium channel, voltage-dependent, P/Q type, alpha 1A subunit, putative Get druggable targets OG5_126791 All targets in OG5_126791
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126791 All targets in OG5_126791
Echinococcus granulosus voltage dependent calcium channel type d subunit|voltage dependent calcium channel|voltage dependent L type calcium channel subu Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum ko:K04850 calcium channel, voltage-dependent, L type, alpha 1C subunit, putative Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum Voltage-dependent calcium channel type A subunit alpha-1, putative Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma mansoni high voltage-activated calcium channel Cav2A Get druggable targets OG5_126791 All targets in OG5_126791
Echinococcus multilocularis voltage dependent calcium channel type d subunit Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma mansoni voltage-gated cation channel Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum Voltage-dependent calcium channel type D subunit alpha-1, putative Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum Voltage-dependent P/Q-type calcium channel subunit alpha-1A, putative Get druggable targets OG5_126791 All targets in OG5_126791
Brugia malayi Voltage-gated calcium channel, L-type, alpha subunit. C. elegans egl-19 ortholog Get druggable targets OG5_126791 All targets in OG5_126791
Echinococcus granulosus voltage dependent calcium channel Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum Voltage-dependent calcium channel type A subunit alpha-1, putative Get druggable targets OG5_126791 All targets in OG5_126791
Echinococcus multilocularis voltage dependent L type calcium channel subunit Get druggable targets OG5_126791 All targets in OG5_126791
Loa Loa (eye worm) calcium channel Get druggable targets OG5_126791 All targets in OG5_126791
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126791 All targets in OG5_126791
Toxoplasma gondii hypothetical protein Get druggable targets OG5_126791 All targets in OG5_126791
Echinococcus multilocularis voltage dependent calcium channel type d subunit Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum ko:K04849 calcium channel, voltage-dependent, N type, alpha 1B subunit, putative Get druggable targets OG5_126791 All targets in OG5_126791
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum Voltage-dependent P/Q-type calcium channel subunit alpha-1A, putative Get druggable targets OG5_126791 All targets in OG5_126791
Trypanosoma brucei Voltage-dependent calcium channel subunit, putative Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum Voltage-dependent N-type calcium channel subunit alpha-1B, putative Get druggable targets OG5_126791 All targets in OG5_126791
Schistosoma japonicum Voltage-dependent calcium channel type D subunit alpha-1, putative Get druggable targets OG5_126791 All targets in OG5_126791

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium ulcerans class a beta-lactamase, BlaC 0.0094 0.5605 1
Echinococcus granulosus voltage dependent calcium channel 0.0093 0.5535 0.5535
Echinococcus granulosus voltage dependent calcium channel type d subunit|voltage dependent calcium channel alpha 1 0.0093 0.5535 0.5535
Leishmania major 0.0142 1 0.5
Toxoplasma gondii sedoheptulose-1,7-bisphosphatase 0.0053 0.186 0.186
Trypanosoma cruzi fructose-1,6-bisphosphatase, cytosolic, putative 0.0142 1 1
Trypanosoma cruzi sedoheptulose-1,7-bisphosphatase, putative 0.0053 0.186 0.186
Echinococcus granulosus fructose 16 bisphosphatase 1 0.0142 1 1
Trypanosoma brucei beta lactamase 0.0045 0.1152 0.1152
Toxoplasma gondii fructose-bisphospatase II 0.0142 1 1
Echinococcus multilocularis fructose 1,6 bisphosphatase 1 0.0142 1 1
Schistosoma mansoni fructose-16-bisphosphatase-related 0.0142 1 1
Loa Loa (eye worm) hypothetical protein 0.0093 0.5535 0.5535
Toxoplasma gondii fructose-bisphospatase I 0.0053 0.186 0.186
Mycobacterium tuberculosis Class a beta-lactamase BlaC 0.0094 0.5605 1
Loa Loa (eye worm) fructose-1,6-bisphosphatase 0.0142 1 1
Loa Loa (eye worm) calcium channel 0.0093 0.5535 0.5535
Trypanosoma brucei fructose-1,6-bisphosphatase 0.0142 1 1
Trypanosoma cruzi sedoheptulose-1,7-bisphosphatase, putative 0.0053 0.186 0.186
Trypanosoma cruzi fructose-1,6-bisphosphatase, cytosolic, putative 0.0142 1 1
Echinococcus granulosus voltage dependent calcium channel type d subunit|voltage dependent calcium channel|voltage dependent L type calcium channel subu 0.0093 0.5535 0.5535
Mycobacterium leprae PROBABLE CONSERVED LIPOPROTEIN LPQF 0.0045 0.1152 0.5
Echinococcus granulosus voltage dependent L type calcium channel subunit|voltage dependent calcium channel 0.0093 0.5535 0.5535
Trypanosoma brucei sedoheptulose-1,7-bisphosphatase 0.0053 0.186 0.186

Activities

Activity type Activity value Assay description Source Reference
Fold reversion (functional) = 59 MDR-reversal property tested in vitro on P388/VCR-20 cells, resistance was induced by vincristine ChEMBL. 8831775
Fold reversion (functional) = 121 MDR-reversal property tested in vitro on KB-A1 cells, resistance was induced by adriamycin ChEMBL. 8831775
Ki (binding) = 5 nM Inhibition of [3H]-D-888 binding to L-type [Ca2+] channel of membranes from rat skeletal muscle ChEMBL. 8831775
Ki (binding) = 5 nM Inhibition of [3H]-D-888 binding to L-type [Ca2+] channel of membranes from rat skeletal muscle ChEMBL. 8831775
T/V (functional) = 1.49 Ratio of survival time of mice treated with VCR (0.25 mg/kg ip)+modulator given at the optimal dose of 100 mg/kg po/survival time of mice treated with VCR alone. ChEMBL. 8831775
Viability (functional) = 95 % Percent of cell viability of P388/VCR-20 murine leukemia cells remaining after inoculation with the modulator alone ChEMBL. 8831775
Viability (functional) = 95 % Percent of cell viability of P388/VCR-20 murine leukemia cells remaining after inoculation with the modulator alone ChEMBL. 8831775
Viability (functional) = 120 % Percent of cell viability of KB-A1 human epidermoid carcinoma remaining after inoculation with the modulator alone ChEMBL. 8831775
Viability (functional) = 120 % Percent of cell viability of KB-A1 human epidermoid carcinoma remaining after inoculation with the modulator alone ChEMBL. 8831775

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.